| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |